Synonyms: Anti-LH3; Anti-Lysyl hydroxylase 3; Anti-Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: PLOD3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) encodes a membrane-bound homodimeric enzyme that catalyzes the hydroxylation of lysyl residues and O-glycosylation of hydroxylysyl residues in collagen-like peptides. The hydroxylysyl groups of these hydroxylysines act as sites of attachment for carbohydrate units and stabilize intermolecular collagen cross-links. The enzyme is localized to the cisternae of the rough endoplasmic reticulum. The gene is mapped to human chromosome 7q36. Deficiency of lysyl hydroxylase activity is observed in some patients with Ehlers-Danlos syndrome type VIB.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC